Institutional Ownership
Arcadia Biosciences Inc
CUSIP 039014204COM NEWRKDAQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Jan 3, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 3, 2025 | Sabby Management, LLC | 13G/A | 4.9% | 68.1K | SEC |
| 2 | Jan 3, 2024 | Sabby Management, LLC | 13G | 8.8% | 97.3K | SEC |
| 3 | Feb 14, 2023 | Armistice Capital, LLC | 13G | 10.0% | 2.68M | SEC |
| 4 | Jan 20, 2023 | Moral Compass Corp | 13D/A | 4.6% | 1.13M | SEC |
| 5 | Feb 11, 2022 | Intracoastal Capital, LLC | 13G/A | 4.6% | 1.06M | SEC |
| 6 | Feb 4, 2022 | Hudson Bay Capital Management LP | 13G/A | 3.9% | 890.0K | SEC |
| 7 | Feb 10, 2021 | Hudson Bay Capital Management LP | 13G/A | 6.2% | 890.0K | SEC |
| 8 | Jan 29, 2021 | Intracoastal Capital, LLC | 13G/A | 5.3% | 745.3K | SEC |
| 9 | Feb 14, 2020 | Anson Funds Management LP | 13G/A | 2.7% | 236.8K | SEC |
| 10 | Feb 14, 2020 | D. E. Shaw & Co, L.P. | 13G/A | 0.2% | 13.5K | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Arcadia Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Harbour Investments, Inc. | 1 | $1 |